Some lactic acid bacteria produce antimicrobial substances called bacteriocins (24) . Several bacteriocins have been isolated and purified, but in only a few cases has the mode of action of these compounds been determined (26) . Nisin (5, 14, 27, 40) , lactostrepcin 5 (50) , and lactococcin A (46) all act on the cytoplasmic membrane of target cells. Although poorly understood, the molecular mechanisms by which these bacteriocins function differ. Many lactic acid bacteria are used in food fermentation, and because of their bacteriocin production, these strains are used as natural food preservatives. Nisin is the only bacteriocin which is commonly used as a purified substance for food preservation (38) .
The genus Pediococcus comprises a large group of lactic acid bacteria that are used commercially in meat (44) and vegetable (35) fermentations. Pediococcus strains that produce bacteriocins are good candidates for food processing and at the same time function in the preservation of processed and fresh food (1, 32, 33) . Purified pediocin has been shown to be a good food preservative (49) . Recently, it has been suggested that Pediococcus strains might also be used as silage inoculants (13) .
In some of the bacteriocin-producing Pediococcus species the genes determining bacteriocin production have been localized on plasmids (8, 18, 19, 22, 32, 39) . In Pediococcus acidilactici PAC1.O, a gene cluster which includes the structural pediocin gene and genes for putative determinants of the pediocin secretion and immunity mechanisms was local-30°C without aeration (2) . The bacteriocin was concentrated from the supernatant by ethanol precipitation and was purified by preparative isoelectric focusing on a Rotofor cell (Bio-Rad Laboratories, Richmond, Calif.) according to the instructions of the supplier. Sakacin P and sakacin A (curvacin A) were isolated and purified as described elsewhere (30, 45) .
Measurement of A*. The transmembrane electrical potential (A+i) in intact cells was determined with an electrode specific for the lipophilic cation tetraphenylphosphonium as described previously (43) .
Transport assays. Amino acid transport by Pediococcus cells was analyzed as described previously for Lactococcus lactis (46, 47) . 1-14C-labeled 2-a-aminoisobutyric acid (AIB) (59 mCi/mmol) and L-[U-14C]glutamate (285 mCi/mmol) were used at final concentrations of 8.5 and 1.75 ,uM, respectively. Uptake of L-[U-14C]leucine by membrane vesicles was analyzed in the presence of an imposed proton motive force or by measuring counterflow as described previously (46) .
Isolation of lipids and preparation of CF-containing liposomes. P. pentosaceus lipids were extracted (9) and washed with acetone-ether as described previously (23) . Unilamellar liposomes with an average diameter of 100 nm were prepared by the method of Goessens et al. (16) . Lipids dissolved in chloroform-methanol (9:1, vol/vol) were thoroughly dried under a vacuum for 1 h. Traces of solvent were removed under a stream of N2. The dry lipid was suspended (6 mg/ml) in a buffer containing 50 mM carboxyfluorescein (CF) and 50 mM K-(2-[N-morpholino]ethanesulfonic acid) (K-MES) (pH 6.0). The lipid suspension was dispersed by ultrasonic irradiation with a bath-sonicator (Sonicor; Sonicor Instruments, New York, N.Y.). Liposomes were obtained by five cycles of freezing in liquid nitrogen and thawing in water at room temperature and were subsequently extruded through 0.4-, 0.2-, and 0.1-,um-pore-size polycarbonate filters (Nuclepore Co., Pleasanton, Calif.) (two times each) by using an extrusion device (Lipex Biomembranes, Vancouver, British Columbia, Canada). Nonencapsulated CF was removed from the liposomes by gel filtration on Sephadex G-75 in 50 mM K-MES. The liposomes were stored on ice until they were used.
Preparation of membrane vesicles and fusion with liposomes. Membrane vesicles of pediocin-sensitive and immune P. pentosaceus cells were prepared by using the procedure described by Driessen (9) . The membrane vesicles (1 mg of protein) were mixed with liposomes composed of P. pentosaceus lipids (13.6 p,mol of phospholipid) in 50 mM K-MES buffer (pH 6.0) and fused by freezing, thawing, and sonication as described previously (11) . Loading of the hybrid membranes with CF was accomplished by adding CF (50 mM) to the thawed hybrid membranes before sonication. Hybrid membranes were collected by centrifugation for 1 h at 280,000 x gm. at 4°C, were washed twice with 50 mM K-MES (pH 6.0) to remove nonencapsulated CF, and finally were resuspended in 100 ,ul of the same buffer.
Fluorescence measurements. Fluorescence measurements were determined with a Perkin-Elmer model LS 50 spectrofluorimeter equipped with a thermostat and a continuous stirring device. The efflux of CF from liposomes or hybrid membranes was measured as described previously (15) . At an intraliposomal CF concentration of 50 mM, the fluorescence of CF is almost completely self-quenched. Release of CF results in a relief of self-quenching which is recorded as an increase in CF fluorescence with an excitation wavelength of 430 nm (at which the inner-filter effect is negligible [16] ) and an emission wavelength of 520 nm. The excitation and emission slit widths were 2.5 and 5.0 nm, respectively. The experiments were performed at a constant temperature of 25°C. Liposomes (70 ,ug of lipid per ml) or hybrid membranes (50 ,ug Efflux of high-molecular-mass fluorescein 5-isothiocyanate (FITC)-labeled dextrans (4.4 and 9.4 kDa) was measured as described previously (15) . The FITC-labeled dextrans were trapped in fused membranes by adding these components to thawed membranes before sonication. The membranes were collected by centrifugation for 1 h at 28,000
x gm. at 4°C and were washed twice with 50 mM K-MES buffer (pH 6.0) to remove nonencapsulated dextrans. The membranes containing FITC-labeled dextrans were suspended in 50 mM K-MES buffer (pH 6.0), and the efflux of the dextrans was determined by monitoring the quenching of fluorescein fluorescence by anti-fluorescein rabbit immunoglobulin G (Molecular Probes, Inc., Eugene, Oreg.). Complete release of the encapsulated dextran was obtained by adding 0.2% (vol/vol) Triton X-100. The excitation and emission wavelengths were 490 and 515 nm, respectively. Slit widths of 10.0 nm were used both for excitation and emission.
Tryptophan fluorescence emission spectra were determined with an SLM-AMINCO model 4800C spectrofluorometer (SLM Instruments, Inc., Urbana, Ill.) from 290 to 400 nm by using an excitation wavelength of 280 nm. Slit widths of 4 nm were used, and the spectra were corrected for background fluorescence and averaged (n = 10) to reduce the noise value.
Other analytic procedures. Protein concentrations in the samples were determined by using the Micro BCA protein assay reagent (Pierce, Rockford, Ill.). CF was purchased from Eastman Kodak Co., Rochester, N.Y., and was purified as described previously (28) by using 50 mM K-MES buffer (pH 6.5) as the eluent.
RESULTS
Pediocin PA-1 is bactericidal for sensitive cells. Pediocin PA-1 inhibits the growth of various bacteria, including the pathogen Listeria monocytogenes (34) . To determine whether pediocin PA-1 acted on a sensitive test culture of P. pentosaceus PPE1.2 wild-type cells in a bacteriostatic, bacteriolytic, or bactericidal manner, the following experiment was conducted. Overnight cultures of wild-type P. pentosaceus PPE1.2 (pediocin sensitive) and a pediocin-insensitive derivative carrying the immunity gene for pediocin PA-1 were diluted in fresh MRS broth containing pediocin PA-1 (5 x 102 AU/mg of protein). Pediocin PA-1 affected neither the growth nor the number of CFU of the immune cells (Fig. 1) . In contrast, the number of CFU of the sensitive organism decreased dramatically. The optical density of the cell culture remained constant. However, after longer periods of time slight increases in both optical density and number of CFU were observed, possibly as a result of inactivation of the pediocin (3). These results indicate that pediocin PA-1 is bactericidal for sensitive P. pentosaceus PPE1. cytoplasmic membrane (46) . Therefore, the effects of pediocin PA-1 on the A4 of sensitive and immune Pediococcus cells were determined. A* (inside negative) was monitored by using an electrode that measured the distribution of the lipophilic cation tetraphenylphosphonium. Pediocin PA-1
(5 AU/mg of protein) caused immediate dissipation of the A*i of intact sensitive cells ( Fig. 2A) , while it had only a minimal effect on the A4 of the immune cells (Fig. 2B ).
It is very likely that pediocin PA-1 eliminates the A* of sensitive cells by changing the ion permeability of the cytoplasmic membrane. To investigate whether pediocin PA-1 elicited efflux of low-molecular-weight solutes, the effect of pediocin PA-1 on amino acid transport was studied. We studied the uptake of two amino acids which differ in their mechanisms of uptake. AIB, a nonmetabolizable analog of alanine, is accumulated in a Ap-dependent manner (25) , whereas L-glutamate is accumulated in a proton motive force (Ap)-independent, most likely ATP-dependent manner (36) . Pediocin PA-1 (500 AU/mg of protein) caused the immediate release of AIB accumulated by P. pentosaceus PPE1.2 cells sensitive to this bacteriocin (Fig. 3A) . In contrast, the ionophore combination valinomycin plus nigericin (1 ,uM each), which completely dissipates the Ap (Fig. 2 4B ) cells of P. pentosaceus PPE1.2 rapidly accumulated leucine when a Ap was generated. The Ap was generated by using valinomycin-mediated outwardly directed diffusion gradients of potassium (A+, inside negative) and acetic acid (chemical gradient of protons across the membrane [ApH], inside alkaline). When membrane vesicles from pediocinsensitive cells were preincubated for 5 min in the presence of pediocin PA-1 (1,000 AU/mg of protein), the ability to accumulate leucine was completely lost (Fig. 4A ). In contrast, membrane vesicles derived from immune cells accumulated a significant level of leucine (Fig. 4B) .
To determine whether pore formation underlies the changes in membrane permeability caused by pediocin, we studied the effect of pediocin PA-1 on leucine counterflow. In these experiments membrane vesicles were loaded with 5 mM leucine and then diluted 50-fold in a medium containing 3.2 ,uM 14C-labeled leucine. Under these conditions, the intravesicular pool of leucine exchanged rapidly with the radiolabeled leucine, which accumulated transiently in response to the outwardly directed leucine concentration gradient (10, 12) . The temporary accumulation of radioactive solute does not require Ap vesicles of the sensitive cells with pediocin PA-1 (1,000 AU/mg of protein) completely destroyed leucine counterflow activity. On the other hand, membrane vesicles of the immune cells exhibited residual leucine counterflow activity when they were incubated with pediocin PA-1 (data not shown). These results suggest that pediocin PA-1 forms pores in isolated cytoplasmic membrane vesicles and that membrane vesicles derived from immune cells are more resistant to pediocin PA-1 than membrane vesicles derived from sensitive cells. (Fig. 5) . However, rapid release of CF when pediocin PA-1 was added was observed in the hybrid membranes prepared with membrane vesicles of both sensitive and immune cells (Fig. 5) .
A similar approach was used to analyze the pediocin PA-1-induced efflux of 4.4-kDa FITC-labeled dextran (data not shown) and 9.4-kDa FITC-labeled dextran (Fig. 6) . Release of FITC-labeled dextran from the hybrid membranes prepared from sensitive membrane vesicles was monitored with anti-fluorescein antibodies which, when present on the outside, quenched the fluorescence of released FITC-labeled dextrans. When pediocin was present at sufficiently high concentrations (2,000 AU/mg of protein), a rapid release of the FITC-labeled dextrans was observed (Fig. 6) . At higher pediocin concentrations (5,000 AU/mg of protein), the efflux of FITC-labeled dextrans was more pronounced. These results suggest that pediocin PA-1 can form large pores that allow membrane passage of highmolecular-weight compounds. Moreover, these results suggest that more pediocin is required to release compounds APPL. ENvIRON. MICROBIOL. having higher molecular weights ( Fig. 1 through 6 ). We concluded that the cytoplasmic membrane is the target of pediocin activity. However, sensitivity to pediocin requires a factor(s) which is not present in liposomes prepared from phospholipids derived from sensitive P. pentosaceus cells.
DTT inhibits pediocin PA-1 activity. The mature region of pediocin PA-1 contains four cysteine residues which form two disulfide bonds (20) . The possible function of these disulfide bonds in pediocin activity was studied by reducing the peptide in the presence of dithiothreitol (DTT). DTItreated pediocin PA-1 had completely lost the ability to kill sensitive cells when it was analyzed in a spot test (data not shown).
Pediocin PA-1 contains two tryptophan residues at positions 19 and 33 and two tyrosine residues at positions 2 and 3. This allowed us to observe qualitative changes in the tertiary structure of the molecule by examining tryptophan fluorescence. When pediocin PA-1 was unfolded in 6 M guanidine-HCl (Fig. 7) , only minor changes in the tryptophan fluorescence spectrum were observed compared with pediocin diluted in buffer. These data suggest that the tryptophan (and tyrosine) residues of pediocin in buffer are exposed to solvent, indicating that the molecule has an unfolded or loose conformation. When pediocin PA-1 was incubated in the presence of Eschenchia coli liposomes, the tryptophan fluorescence emission spectrum was broadened with a blue shift of the emission maximum. These data suggest that the tryptophan residues were transferred from a polar environment to a nonpolar environment, possibly as a result of membrane insertion or a lipid-induced conformational change of the molecule. Similar changes in the fluorescence spectrum were obtained when pediocin PA-1 was incubated in the presence of DTT, although the maximum fluorescence was decreased because of inner-filter effects caused by near-UV absorbance by DTT (data not shown). Quenching of the tryptophan fluorescence by water-soluble acrylamide was more efficient with the soluble pediocin ( tryptophan residues of pediocin PA-1 are localized on the surface when pediocin PA-1 is associated with liposomes. The peptide may assume a more ordered structure upon interaction with the membrane surface irrespective of the reduction state of its disulfide bonds.
DISCUSSION
Pediocin PA-1 belongs to a group of bacteriocins produced by Pediococcus spp. (7, 24, 29, 39) . In this study we examined the mode of action of pediocin PA-1. Our data suggest that pediocin PA-1 kills sensitive cells by effecting the release of metabolites by the formation of pores in the target membranes.
Recently, the amino acid sequence of pediocin AcH was described on the basis of both an amino acid sequence determination and the sequence derived from the nucleotide sequence of the gene (33 (7) . The latter bacteriocin may be identical to pediocin PA-1 (AcH). Our data suggest that the concentration of pediocin determines the size exclusion limit of the pores. Only at higher concentrations was effective release of the high-molecular-weight dextrans observed, while lower concentrations of pediocin were sufficient to dissipate the Ap. The lantibiotic nisin, however, does not cause the release of dextrans from liposomes (15) .
Reduction of the disulfide bonds in pediocin PA-1 resulted in a complete loss of bacteriocin activity. It has been reported that the cysteine residues present in sakacin A are in a reduced state (4) , while the cysteine residues in pediocin PA-1 are in an oxidized state, forming disulfide bonds (20) . Two cysteine residues of pediocin PA-1, sakacin A (curvacin A), and sakacin P are in the same positions (i.e., at position 9 or 10 and at position 14 or 15) in the primary structures of the aligned sequences. The additional cysteine residues of pediocin PA-1 at positions 24 and 44 are not present in sakacin A and sakacin P. Since D1T does not inhibit the antimicrobial activities of sakacin A and sakacin P (6), it seems likely that the disulfide bond between the cysteine residues at positions 24 and 44 is essential for pediocin PA-1 activity.
Pediocin PA-1 is ineffective against liposomes composed of P. pentosaceus PPE1.2 phospholipids, but it does affect hybrid membrane vesicles of this organism fused with liposomes composed of both P. pentosaceus and E. coli phospholipids (6). E. coli cells are not sensitive to pediocin PA-1. These data suggest that there is a requirement for a protein in the target membrane, as suggested for lactococcin A (46), a bacteriocin produced by certain Lactococcus lactis strains, rather than for a lipid component. Pediococcus cells which synthesize the pediocin immunity protein are highly resistant to pediocin PA-1 treatment. This property is partially pre-served in membrane vesicles derived from immune cells. A similar phenomenon has been observed with lactococcin A (46) . On the other hand, the immunity phenotype appears to be lost when these membrane vesicles are fused with liposomes composed of Pediococcus phospholipids. The reason for this observation is not known. Loss of the resistant phenotype could be a result of inactivation or loss of the immunity protein in the fused membranes. Proteinase K treatment of membrane vesicles derived from both immune and sensitive cells resulted in increased resistance of the membrane vesicles of sensitive cells and decreased resistance of membrane vesicles of immune cells (6) . This implies that there is a complicated mechanism of immunity in which the immunity protein is not the only protein that participates.
